Response to Fullarton et al
J Infect Dis
.
2023 May 29;227(11):1335-1336.
doi: 10.1093/infdis/jiac489.
Authors
Alexia Kieffer
1
,
Matthieu Beuvelet
1
,
Aditya Sardesai
2
,
Robert Musci
2
,
Sandra Milev
2
,
Jason K H Lee
3
Affiliations
1
Sanofi, Lyon, France.
2
Evidera, San Francisco, California, USA.
3
Sanofi, Toronto, Ontario, Canada.
PMID:
36519404
PMCID:
PMC10226654
DOI:
10.1093/infdis/jiac489
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
Comment